Patients who lack the early components of the classical complement pathway, including complement 3 (C3) and complement 4 (C4), often exhibit clinical renal SLE symptoms in addition to susceptibility to infection, indicating the development of immunosuppressive effects of SLE [8, 9]. The gene discussed is C4A; the disease is systemic lupus erythematosus.